| (HKD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 269.58M | -33.80% |
| Operating expense | — | — |
| Net income | -437.00M | 379.13% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 2616.HK returned -42.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +4.3% |
| 1 year | -42.4% |
| 5 years | -57.6% |
| All-time high | $17.10 (Jun 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 2616.HK would be worth today ›No. CStone Pharmaceuticals has not paid a dividend in the past 12 months.
CStone Pharmaceuticals is part of the Healthcare sector.
CStone Pharmaceuticals has a market cap of 8.85B HKD, based on the latest quote.
CStone Pharmaceuticals is scheduled to report earnings on Aug 27, 2026.
